Search Results - "Vora, Sheetal"

Refine Results
  1. 1
  2. 2
  3. 3

    Implementation Science in Pediatric Rheumatology: A Path to Health Equity by Smitherman, Emily A., Goh, Ingrid, Pooni, Rajdeep, Vora, Sheetal S., Yildirim-Toruner, Cagri, von Scheven, Emily

    “…Implementation science is the study of processes that promote reliable uptake of evidence-based practices into clinical care. The integration of implementation…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Navigating the path to equitable rheumatologic care for underserved children with quality improvement by Vora, Sheetal S, Mabus, Sarah C, Buitrago-Mogollon, Talia L

    Published in Frontiers in pediatrics (15-10-2024)
    “…The aim of this quality improvement project is to identify children with rheumatologic conditions to prevent delayed or missed diagnosis in underserved…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Key data elements for a successful pediatric rheumatology virtual visit: a survey within the PR-COIN network by Goh, Y. Ingrid, Ryan, Meghan E., Akoghlanian, Shoghik, Pooni, Rajdeep, Harris, Julia G., Bullock, Danielle R., Vora, Sheetal S., Lee, Tzielan C., Tse, Shirley M.L., Barbar-Smiley, Fatima

    Published in Frontiers in pediatrics (22-10-2024)
    “…Introduction Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease which is commonly monitored by a combination of history,…”
    Get full text
    Journal Article
  9. 9

    Assessing disparities through missing race and ethnicity data: results from a juvenile arthritis registry by Banschbach, Katelyn M, Singleton, Jade, Wang, Xing, Vora, Sheetal S, Harris, Julia G, Lytch, Ashley, Pan, Nancy, Klauss, Julia, Fair, Danielle, Hammelev, Erin, Gilbert, Mileka, Kreese, Connor, Machado, Ashley, Tarczy-Hornoch, Peter, Morgan, Esi M

    Published in Frontiers in pediatrics (24-07-2024)
    “…Ensuring high-quality race and ethnicity data within the electronic health record (EHR) and across linked systems, such as patient registries, is necessary to…”
    Get full text
    Journal Article
  10. 10

    A Quality Improvement Approach to Ensuring Access to Specialty Care for Pediatric Patients by Vora, Sheetal S., Buitrago-Mogollon, Talia L., Mabus, Sarah C.

    Published in Pediatric quality & safety (01-05-2022)
    “…Introduction: With pediatric rheumatologists in short supply, maximizing appointment availability and streamlining primary/specialty collaboration are…”
    Get full text
    Journal Article
  11. 11

    Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices by Brinkman, William B, Lipstein, Ellen A, Taylor, Janalee, Schoettker, Pamela J, Naylor, Katherine, Jones, Karla, Vora, Sheetal S, Mims, Catherine C, Roth-Wojcicki, Elizabeth, Gottlieb, Beth, Griffin, Nancy, Lannon, Carole, Morgan, Esi

    Published in Pediatric rheumatology online journal (05-06-2017)
    “…Randomized trials have demonstrated the efficacy of patient decision aids to facilitate shared decision making in clinical situations with multiple medically…”
    Get full text
    Journal Article
  12. 12

    Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network by Goh, Y Ingrid, Bullock, Danielle R, Taylor, Janalee, Pooni, Rajdeep, Lee, Tzielan C, Vora, Sheetal S, Yildirim-Toruner, Cagri, Morgan, Esi M, Pan, Nancy, Harris, Julia G, Warmin, Andrew, Wiegand, Kendra, Burnham, Jon M, Barbar-Smiley, Fatima

    Published in Frontiers in pediatrics (04-03-2021)
    “…Healthcare providers were rapidly forced to modify the way they practiced medicine during the coronavirus disease 2019 (COVID-19) pandemic. Many providers…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome by Kessler, Elizabeth A, Vora, Sheetal S, Verbsky, James W

    Published in Pediatric rheumatology online journal (29-08-2012)
    “…Tocilizumab (TCZ) is the first FDA- approved treatment for systemic juvenile idiopathic arthritis (sJIA). We report 3 cases of cytopenias in children with sJIA…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Respiratory symptoms in children with Ehlers-Danlos syndrome by Harris, Julia G., MD, Khiani, Sanjay J., MD, Lowe, Sara A., MSN, Vora, Sheetal S., MD

    “…Pulmonary function measurements included a forced expiratory volume in 1 second (FEV1) of 96%-124% predicted, and an FEV1 to forced vital capacity (FVC) ratio…”
    Get full text
    Journal Article
  20. 20

    An evaluation of the utility of routine laboratory monitoring of juvenile idiopathic arthritis (JIA) patients using non-steroidal anti-inflammatory drugs (NSAIDs): a retrospective review by Vora, Sheetal S, Bengtson, Christine E, Syverson, Grant D, Nocton, James J

    Published in Pediatric rheumatology online journal (14-04-2010)
    “…No consensus evidence-based guidelines for the routine laboratory monitoring of children with JIA receiving non-steroidal anti-inflammatory drugs (NSAIDs)…”
    Get full text
    Journal Article